Paid Clinical Trials Overland Park
Discover 780 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Danvatirsen & PembrolizumabActivity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Sponsor:
Flamingo Therapeutics NV
Location:
Code:
NCT05814666
Conditions
HNSCC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Danvatirsen
Pembrolizumab
Rexlemestrocel-L & HAEfficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
Sponsor:
Mesoblast, Ltd.
Location:
Code:
NCT06325566
Conditions
Degenerative Disc Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rexlemestrocel-L + HA mixture
Saline
Pembrolizumab with GemcitabineTesting the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04164082
Conditions
Bladder Flat Urothelial Carcinoma In Situ
Non-Muscle Invasive Bladder Urothelial Carcinoma
Stage 0a Bladder Cancer AJCC v8
Stage 0is Bladder Cancer AJCC v8
Stage I Bladder Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Computed Tomography
Cystoscopy
Gemcitabine Hydrochloride
Acolbifene vs. TamoxifenAcolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05941520
Conditions
Breast Atypical Hyperplasia
Breast Carcinoma
Breast Ductal Carcinoma In Situ
Breast Lobular Carcinoma In Situ
Eligibility Criteria
Sex: Female
Age: 35+
Healthy Volunteers: Not accepted
Interventions
Acolbifene Hydrochloride
Biospecimen Collection
Mammography
Questionnaire Administration
Random Periareolar Fine-Needle Aspiration
AF AblationObservational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
Sponsor:
Kansas City Heart Rhythm Research Foundation
Location:
Code:
NCT05826665
Conditions
Persistent Atrial Fibrillation
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Persistent AF ablation assisted with the STAR Apollo Mapping System
Gonadal Vein EmbolizationQuantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT03794466
Conditions
Pelvic Congestive Syndrome
Pelvic Pain
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
NICU AntibioticsNICU Antibiotics and Outcomes Trial
Sponsor:
Michael Morowitz
Location:
Code:
NCT03997266
Conditions
Microbial Colonization
Extreme Prematurity
Early-Onset Neonatal Sepsis
Late-Onset Neonatal Sepsis
Necrotizing Enterocolitis of Newborn
Eligibility Criteria
Sex: All
Age: 0 - 4
Healthy Volunteers: Not accepted
Interventions
Ampicillin
Gentamycin
Normal saline
Rinatabart SesutecanRinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor:
Genmab
Location:
Code:
NCT05579366
Conditions
Platinum-Resistant Ovarian Cancer
Platinum Sensitive Ovarian Cancer (PSOC)
High Grade Epithelial Ovarian Cancer
High Grade Serous Ovarian Cancer
Primary Peritoneal Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rina-S
Carboplatin
Bevacizumab
Pembrolizumab
Anorexia NervosaSmart Technology for Anorexia Nervosa Recovery
Sponsor:
University of Kansas
Location:
Code:
NCT05190926
Conditions
Anorexia Nervosa
Eligibility Criteria
Sex: All
Age: 13 - 21
Healthy Volunteers: Not accepted
Interventions
Smart-Treatment for Anorexia Nervosa Recovery (STAR)
Present-focused Anorexia Nervosa Coping Treatment (PACT)
Observational StudyA Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Sponsor:
Target PharmaSolutions, Inc.
Location:
Code:
NCT03661866
Conditions
Atopic Dermatitis
Alopecia Areata
Hidradenitis Suppurativa
Vitiligo
Psoriasis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted